We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

133 hedge funds and large institutions have $1.19B invested in Translate Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 46 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

656% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 9

318% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 11

127% more capital invested

Capital invested by funds: $525M → $1.19B (+$666M)

80% more funds holding

Funds holding: 74133 (+59)

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

27% more call options, than puts

Call options by funds: $6.25M | Put options by funds: $4.94M

Holders
133
Holders Change
+59
Holders Change %
+79.73%
% of All Funds
2.73%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
68
Increased
46
Reduced
11
Closed
9
Calls
$6.25M
Puts
$4.94M
Net Calls
+$1.31M
Net Calls Change
+$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$1.43M +$686K +45,500 +132%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$1.37M +$344K +22,786 +43%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$1.23M +$414K +27,470 +67%
Citigroup
54
Citigroup
New York
$1.18M +$740K +49,095 +292%
ECM
55
Element Capital Management
New York
$1.1M +$924K +61,297 New
MAM
56
Monaco Asset Management
Monaco
$1.07M +$905K +60,000 New
State of Wisconsin Investment Board
57
State of Wisconsin Investment Board
Wisconsin
$1.01M +$48.3K +3,200 +6%
CS
58
Credit Suisse
Switzerland
$939K +$789K +52,352 New
TD Asset Management
59
TD Asset Management
Ontario, Canada
$927K +$780K +51,712 New
Dimensional Fund Advisors
60
Dimensional Fund Advisors
Texas
$921K -$31.9K -2,115 -4%
PPA
61
Parametric Portfolio Associates
Washington
$897K +$755K +50,057 New
Barclays
62
Barclays
United Kingdom
$847K +$539K +35,746 +311%
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$831K +$329K +21,800 +89%
Morgan Stanley
64
Morgan Stanley
New York
$793K +$223K +14,810 +50%
FAM
65
Fred Alger Management
New York
$717K +$603K +40,000 New
Grantham, Mayo, Van Otterloo & Co (GMO)
66
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$706K +$594K +39,400 New
UBS Group
67
UBS Group
Switzerland
$578K +$149K +9,903 +44%
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$568K +$112K +7,419 +33%
AIG
69
American International Group
New York
$555K +$158K +10,446 +51%
Russell Investments Group
70
Russell Investments Group
United Kingdom
$548K +$461K +30,585 New
BC
71
Birchview Capital
Vermont
$538K
Bank of America
72
Bank of America
North Carolina
$511K +$230K +15,223 +115%
Deutsche Bank
73
Deutsche Bank
Germany
$511K +$244K +16,185 +131%
VF
74
Virtu Financial
New York
$507K +$426K +28,274 New
Jennison Associates
75
Jennison Associates
New York
$452K +$380K +25,216 New

TBIO Hedge Fund Activity: Q2 2020 in Review

133 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q2 2020, worth a combined $1.19B — up 127% from $525M a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new TBIO positions and 9 closed out — a net gain of 59 holders — while 46 added to existing stakes and 11 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $26.9M. The largest seller was Omega Fund Management, exiting entirely with an estimated $24.3M sold.

  • 133 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q2 2020, up from 74 in Q1 2020.
  • Funds reported $1.19B of Translate Bio, Inc. Common Stock stock for Q2 2020, up 127% quarter-over-quarter.
  • 68 funds opened new Translate Bio, Inc. Common Stock positions in Q2 2020 and 9 closed out, a net change of +59 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q2 2020 was T. Rowe Price Associates, an estimated $26.9M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q2 2020 was Omega Fund Management, an estimated $24.3M sold.

Based on aggregated 13F filings for Q2 2020.